C-Reactive Protein-Albumin Ratio (CAR): A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma
Rong-Yun Mai,Ting-Li Lu,Ri-Jin Lu,Can Zeng,Fang Lian,Le-Qun Li,Guo-Bin Wu,Jia-Zhou Ye
DOI: https://doi.org/10.2147/jir.s441623
IF: 4.5
2024-02-13
Journal of Inflammation Research
Abstract:Rong-Yun Mai, 1, &ast Ting-Li Lu, 1, &ast Ri-Jin Lu, 1 Can Zeng, 1 Fang Lian, 2 Le-Qun Li, 1 Guo-Bin Wu, 1 Jia-Zhou Ye 1 1 Department of Hepatobiliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, Nanning, 530021, People's Republic of China; 2 Department of Physiology, Basic Medical College, Guangxi Medical University, Nanning, 530021, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jia-Zhou Ye; Guo-Bin Wu, Department of Hepatobiliary & Pancreatic Surgery, Guangxi Medical University Cancer Hospital, 71 He Di Road, Nanning, 530021, People's Republic of China, Tel +86-771-5310045, Fax +86-771-5312000, Email ; Background: Systemic inflammatory response is a hallmark of cancer and plays a significant role in the development and progression of various malignant tumors. This research aimed to estimate the prognostic function of the C-reactive protein-albumin ratio (CAR) in patients undergoing hepatectomy for hepatocellular carcinoma (HCC) and compare it with other inflammation-based prognostic scores, including the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, monocyte-lymphocyte ratio, systemic immune inflammation index, prognostic index, Glasgow prognostic score, and modified Glasgow prognostic score. Methods: Retrospective analysis was conducted on data from 1039 HCC cases who underwent curative liver resection. The prognostic performance of CAR was compared with other scores using the area under the time-dependent receiver operating characteristic (t-ROC) curve. Multivariable Cox regression analyses were performed to confirm independent predictors for disease-free survival (DFS) and overall survival (OS). Results: The area under the t-ROC curve for CAR in the evaluation of DFS and OS was significantly greater than that of other scores and alpha-fetoprotein (AFP). Patients were stratified based on the optimal cut-off value of CAR, and the data revealed that both DFS and OS were remarkably worse in the high-CAR set compared to the low-CAR set. Multivariable Cox analysis demonstrated that CAR was an independent prognostic parameters for assessing DFS and OS. Regardless of AFP levels, all patients were subsequently divided into significantly different subgroups of DFS and OS based on CAR risk stratification. Similar results were observed when applying CAR risk stratification to other scoring systems. CAR also showed good clinical applicability in patients with different clinical features. Conclusion: CAR is a more effective inflammation-based prognostic marker than other scores and AFP in predicting DFS as well as OS among patients with HCC after curative hepatectomy. Keywords: hepatocellular carcinoma, hepatectomy, systemic inflammation response, inflammation-based prognostic marker, C-reactive protein to albumin ratio Hepatectomy is a major radical therapy method for resectable hepatocellular carcinoma (HCC) patients. 1–3 However, the majority of experience high recurrence rates after surgery, leading to unsatisfactory long-time survival. 4 Thus, the recognition of high-risk patients with poor outcomes using an accurate, efficient, and convenient preoperative model is of great significance allowing for the optimization of adjuvant therapy and improvement of the long-term prognosis for patients. Currently, growing research has revealed that systemic inflammatory response (SIR) exerts a key effect in tumorigenesis and progression, and is relevant to the adverse outcomes of many patients with malignant tumors. 5–8 Numerous researches have determined the relevance of inflammation-based prognostic scores (IBPS) to the prognosis of multiple types of tumors. 9,10 These IBPSs typically consist of acute phase proteins and leukocytes from the circulatory system. The neutrophil lymphocyte ratio (NLR), a predictive model on the basis of circulating leukocytes, has been extensively studied 11 and has shown satisfactory prognostic value in different cancer patients. 12–14 Other studies have also found that the platelet lymphocyte ratio (PLR), 15,16 monocyte lymphocyte ratio (MLR), 17,18 systemic immune inflammation index (SII) 19,20 as well as prognostic index (PI) 10,21 are closely involved in the outcomes of many cancer patients. Nevertheless, a significant proportion of HCC patients receive adjuvant therapy before hepatectomy, such as hepatic artery infusion chemotherapy, targeted therapy, and radiofrequency ablation, which can reduce the number of circulating inflammatory cells, such as neutrophils, lymphocytes, mon -Abstract Truncated-
immunology